CLINICAL_TRIALS
trial_result
· 2011-07-06
Clinical Trial Update: Methotrexate-Inadequate Response Study [Phase 3]
Summary
Phase 3 trial for abatacept in methotrexate-inadequate responders with rheumatoid arthritis completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis (RA) | Phase 3 | Status: COMPLETED | Results posted: 2011-07-06